ALXP
ALSAF
Market cap129kUSD
Jun 30, Last price
0.64EUR
Name
Safe SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating as a medical technology firm, Safe Orthopaedics SA specializes in the creation and global distribution of sterile implants and disposable surgical tools designed to address spinal fracture conditions. Its innovative product line includes SteriSpine PS, a comprehensive system for managing both spinal fractures and degenerative spine issues. Additionally, they provide SteriSpine VA, a versatile suite encompassing pre-packaged Kyphoplasty and Cement solutions. The portfolio further extends to SteriSpine LC, offering pre-assembled instrumentation for lumbar cages like Cedar and Elm, and SteriSpine CC, which provides similar ready-to-use instruments for cervical cages, exemplified by Walnut. Established in 2010, the company's main operations are based in Éragny-sur-Oise, France.
Key people
Alain Coudray
Independent Chairman of the Board
Pierre Dumouchel
Chief Executive Officer · since 2016
Francois-Henri Reynaud
Chief Financial and Administrative Officer
Sjors Hermans
Senior Vice President of Sales
Sven Claes
Director of Marketing
Katy Fraisse
Director of Human Resources
Thomas Droulout
Technical Director
Stephanie Robert
Director of Quality and Reglemantary Affairs
Marie-Yvonne Landel-Meunier
Independent Director · since 2015
Dominique Petit
Independent Director · since 2018
Headquarters & legal address
80 RUE DE MONTEPY
ZA DE MONTEPY
FLEURIEUX-SUR-L'ARBRESLE 69210
FR
ZA DE MONTEPY
FLEURIEUX-SUR-L'ARBRESLE 69210
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY |
|---|---|
| 2025‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |